nodes	percent_of_prediction	percent_of_DWPC	metapath
Rosuvastatin—SLCO1B3—Mycophenolate mofetil—systemic scleroderma	0.107	0.144	CbGbCtD
Rosuvastatin—ABCG2—Leflunomide—systemic scleroderma	0.0804	0.108	CbGbCtD
Rosuvastatin—SLCO1B1—Mycophenolate mofetil—systemic scleroderma	0.0625	0.0836	CbGbCtD
Rosuvastatin—SLCO1A2—Prednisone—systemic scleroderma	0.053	0.0709	CbGbCtD
Rosuvastatin—ABCG2—Mycophenolate mofetil—systemic scleroderma	0.0497	0.0664	CbGbCtD
Rosuvastatin—ALB—Captopril—systemic scleroderma	0.0435	0.0582	CbGbCtD
Rosuvastatin—SLCO1B3—Methotrexate—systemic scleroderma	0.0431	0.0576	CbGbCtD
Rosuvastatin—ABCC4—Methotrexate—systemic scleroderma	0.037	0.0495	CbGbCtD
Rosuvastatin—ALB—Mycophenolate mofetil—systemic scleroderma	0.0342	0.0458	CbGbCtD
Rosuvastatin—CYP2C9—Leflunomide—systemic scleroderma	0.0299	0.0399	CbGbCtD
Rosuvastatin—ABCC1—Methotrexate—systemic scleroderma	0.0298	0.0398	CbGbCtD
Rosuvastatin—CYP3A5—Mycophenolate mofetil—systemic scleroderma	0.0275	0.0368	CbGbCtD
Rosuvastatin—ALB—Prednisone—systemic scleroderma	0.0274	0.0366	CbGbCtD
Rosuvastatin—SLCO1A2—Methotrexate—systemic scleroderma	0.0266	0.0355	CbGbCtD
Rosuvastatin—SLCO1B1—Methotrexate—systemic scleroderma	0.0251	0.0335	CbGbCtD
Rosuvastatin—SLC7A11—forelimb zeugopod—systemic scleroderma	0.0217	0.355	CbGeAlD
Rosuvastatin—ABCG2—Methotrexate—systemic scleroderma	0.0199	0.0266	CbGbCtD
Rosuvastatin—CYP2C19—Prednisone—systemic scleroderma	0.0177	0.0237	CbGbCtD
Rosuvastatin—ALB—Methotrexate—systemic scleroderma	0.0137	0.0184	CbGbCtD
Rosuvastatin—CYP2C9—cardial valve—systemic scleroderma	0.012	0.198	CbGeAlD
Rosuvastatin—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.0107	0.0144	CbGbCtD
Rosuvastatin—CYP3A4—Prednisone—systemic scleroderma	0.00858	0.0115	CbGbCtD
Rosuvastatin—SLC7A11—smooth muscle tissue—systemic scleroderma	0.00219	0.036	CbGeAlD
Rosuvastatin—SLC7A11—digestive system—systemic scleroderma	0.00173	0.0284	CbGeAlD
Rosuvastatin—ABCB11—digestive system—systemic scleroderma	0.00154	0.0252	CbGeAlD
Rosuvastatin—HMGCR—connective tissue—systemic scleroderma	0.00149	0.0245	CbGeAlD
Rosuvastatin—SLCO1B3—lung—systemic scleroderma	0.00149	0.0244	CbGeAlD
Rosuvastatin—SLC7A11—lung—systemic scleroderma	0.00145	0.0237	CbGeAlD
Rosuvastatin—HMGCR—smooth muscle tissue—systemic scleroderma	0.00136	0.0224	CbGeAlD
Rosuvastatin—HMGCR—skin of body—systemic scleroderma	0.00135	0.0221	CbGeAlD
Rosuvastatin—SLC7A11—Dexamethasone—Mometasone—systemic scleroderma	0.00116	0.324	CbGdCrCtD
Rosuvastatin—SLC7A11—Betamethasone—Mometasone—systemic scleroderma	0.00116	0.324	CbGdCrCtD
Rosuvastatin—HMGCR—digestive system—systemic scleroderma	0.00108	0.0177	CbGeAlD
Rosuvastatin—SLCO1B1—digestive system—systemic scleroderma	0.00103	0.0169	CbGeAlD
Rosuvastatin—HMGCR—tendon—systemic scleroderma	0.00103	0.0168	CbGeAlD
Rosuvastatin—SLCO2B1—digestive system—systemic scleroderma	0.000913	0.015	CbGeAlD
Rosuvastatin—HMGCR—lung—systemic scleroderma	0.0009	0.0148	CbGeAlD
Rosuvastatin—SLCO2B1—tendon—systemic scleroderma	0.000869	0.0142	CbGeAlD
Rosuvastatin—SLCO1A2—digestive system—systemic scleroderma	0.00084	0.0138	CbGeAlD
Rosuvastatin—ABCC4—digestive system—systemic scleroderma	0.000808	0.0133	CbGeAlD
Rosuvastatin—ABCC4—tendon—systemic scleroderma	0.000769	0.0126	CbGeAlD
Rosuvastatin—SLCO2B1—lung—systemic scleroderma	0.000762	0.0125	CbGeAlD
Rosuvastatin—SLCO1A2—lung—systemic scleroderma	0.000701	0.0115	CbGeAlD
Rosuvastatin—ABCC4—lung—systemic scleroderma	0.000675	0.0111	CbGeAlD
Rosuvastatin—CYP2C19—digestive system—systemic scleroderma	0.000672	0.011	CbGeAlD
Rosuvastatin—ABCC1—tendon—systemic scleroderma	0.000656	0.0108	CbGeAlD
Rosuvastatin—SLC7A11—Betamethasone—Prednisone—systemic scleroderma	0.000633	0.176	CbGdCrCtD
Rosuvastatin—SLC7A11—Dexamethasone—Prednisone—systemic scleroderma	0.000633	0.176	CbGdCrCtD
Rosuvastatin—ABCC1—lung—systemic scleroderma	0.000576	0.00944	CbGeAlD
Rosuvastatin—CYP3A5—digestive system—systemic scleroderma	0.00053	0.00869	CbGeAlD
Rosuvastatin—CYP2C9—digestive system—systemic scleroderma	0.000521	0.00855	CbGeAlD
Rosuvastatin—ABCG2—lung—systemic scleroderma	0.000477	0.00782	CbGeAlD
Rosuvastatin—Paraesthesia—Mometasone—systemic scleroderma	0.000454	0.00242	CcSEcCtD
Rosuvastatin—Mental disorder—Leflunomide—systemic scleroderma	0.000451	0.0024	CcSEcCtD
Rosuvastatin—Confusional state—Captopril—systemic scleroderma	0.000448	0.00239	CcSEcCtD
Rosuvastatin—Dyspepsia—Mometasone—systemic scleroderma	0.000445	0.00237	CcSEcCtD
Rosuvastatin—Rhinitis—Lisinopril—systemic scleroderma	0.000444	0.00236	CcSEcCtD
Rosuvastatin—Hepatitis—Lisinopril—systemic scleroderma	0.000443	0.00236	CcSEcCtD
Rosuvastatin—CYP3A5—lung—systemic scleroderma	0.000442	0.00726	CbGeAlD
Rosuvastatin—Flatulence—Leflunomide—systemic scleroderma	0.000442	0.00235	CcSEcCtD
Rosuvastatin—Pharyngitis—Lisinopril—systemic scleroderma	0.000439	0.00234	CcSEcCtD
Rosuvastatin—Arrhythmia—Mycophenolic acid—systemic scleroderma	0.000439	0.00234	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Prednisone—systemic scleroderma	0.000437	0.00233	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Captopril—systemic scleroderma	0.000435	0.00232	CcSEcCtD
Rosuvastatin—Pain—Mometasone—systemic scleroderma	0.000432	0.0023	CcSEcCtD
Rosuvastatin—Hypersensitivity—Pentoxifylline—systemic scleroderma	0.000432	0.0023	CcSEcCtD
Rosuvastatin—Depression—Mycophenolate mofetil—systemic scleroderma	0.000431	0.0023	CcSEcCtD
Rosuvastatin—Mental disorder—Mycophenolic acid—systemic scleroderma	0.000431	0.00229	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Mycophenolate mofetil—systemic scleroderma	0.000423	0.00226	CcSEcCtD
Rosuvastatin—Flatulence—Mycophenolic acid—systemic scleroderma	0.000422	0.00225	CcSEcCtD
Rosuvastatin—Jaundice—Mycophenolate mofetil—systemic scleroderma	0.000421	0.00224	CcSEcCtD
Rosuvastatin—Asthenia—Pentoxifylline—systemic scleroderma	0.00042	0.00224	CcSEcCtD
Rosuvastatin—Urinary tract infection—Mycophenolate mofetil—systemic scleroderma	0.00042	0.00224	CcSEcCtD
Rosuvastatin—Pruritus—Pentoxifylline—systemic scleroderma	0.000415	0.00221	CcSEcCtD
Rosuvastatin—Injury—Prednisone—systemic scleroderma	0.000413	0.0022	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mometasone—systemic scleroderma	0.000413	0.0022	CcSEcCtD
Rosuvastatin—Haematuria—Mycophenolate mofetil—systemic scleroderma	0.000412	0.00219	CcSEcCtD
Rosuvastatin—Angioedema—Leflunomide—systemic scleroderma	0.00041	0.00218	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Mycophenolate mofetil—systemic scleroderma	0.000409	0.00218	CcSEcCtD
Rosuvastatin—Sinusitis—Mycophenolate mofetil—systemic scleroderma	0.000405	0.00216	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Captopril—systemic scleroderma	0.000405	0.00216	CcSEcCtD
Rosuvastatin—Amnesia—Prednisone—systemic scleroderma	0.000404	0.00216	CcSEcCtD
Rosuvastatin—Myalgia—Azathioprine—systemic scleroderma	0.000404	0.00215	CcSEcCtD
Rosuvastatin—Arthralgia—Azathioprine—systemic scleroderma	0.000404	0.00215	CcSEcCtD
Rosuvastatin—Insomnia—Captopril—systemic scleroderma	0.000402	0.00214	CcSEcCtD
Rosuvastatin—Diarrhoea—Pentoxifylline—systemic scleroderma	0.000401	0.00214	CcSEcCtD
Rosuvastatin—Abdominal pain—Mometasone—systemic scleroderma	0.0004	0.00213	CcSEcCtD
Rosuvastatin—Paraesthesia—Captopril—systemic scleroderma	0.000399	0.00212	CcSEcCtD
Rosuvastatin—CYP3A4—digestive system—systemic scleroderma	0.000397	0.00652	CbGeAlD
Rosuvastatin—Arrhythmia—Lisinopril—systemic scleroderma	0.000395	0.00211	CcSEcCtD
Rosuvastatin—Gynaecomastia—Methotrexate—systemic scleroderma	0.000391	0.00209	CcSEcCtD
Rosuvastatin—Cough—Leflunomide—systemic scleroderma	0.000391	0.00209	CcSEcCtD
Rosuvastatin—Dyspepsia—Captopril—systemic scleroderma	0.000391	0.00208	CcSEcCtD
Rosuvastatin—Rhinitis—Mycophenolate mofetil—systemic scleroderma	0.000389	0.00207	CcSEcCtD
Rosuvastatin—Hepatitis—Mycophenolate mofetil—systemic scleroderma	0.000388	0.00207	CcSEcCtD
Rosuvastatin—Mental disorder—Lisinopril—systemic scleroderma	0.000388	0.00207	CcSEcCtD
Rosuvastatin—Dizziness—Pentoxifylline—systemic scleroderma	0.000387	0.00206	CcSEcCtD
Rosuvastatin—Infection—Azathioprine—systemic scleroderma	0.000385	0.00205	CcSEcCtD
Rosuvastatin—Pharyngitis—Mycophenolate mofetil—systemic scleroderma	0.000385	0.00205	CcSEcCtD
Rosuvastatin—Arthralgia—Leflunomide—systemic scleroderma	0.000382	0.00203	CcSEcCtD
Rosuvastatin—Myalgia—Leflunomide—systemic scleroderma	0.000382	0.00203	CcSEcCtD
Rosuvastatin—Constipation—Captopril—systemic scleroderma	0.00038	0.00202	CcSEcCtD
Rosuvastatin—Flatulence—Lisinopril—systemic scleroderma	0.00038	0.00202	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Azathioprine—systemic scleroderma	0.000379	0.00202	CcSEcCtD
Rosuvastatin—Cough—Mycophenolic acid—systemic scleroderma	0.000373	0.00199	CcSEcCtD
Rosuvastatin—Rash—Pentoxifylline—systemic scleroderma	0.000369	0.00197	CcSEcCtD
Rosuvastatin—Dermatitis—Pentoxifylline—systemic scleroderma	0.000369	0.00197	CcSEcCtD
Rosuvastatin—Headache—Pentoxifylline—systemic scleroderma	0.000367	0.00196	CcSEcCtD
Rosuvastatin—Feeling abnormal—Captopril—systemic scleroderma	0.000366	0.00195	CcSEcCtD
Rosuvastatin—Diabetes mellitus—Methotrexate—systemic scleroderma	0.000365	0.00195	CcSEcCtD
Rosuvastatin—Myalgia—Mycophenolic acid—systemic scleroderma	0.000364	0.00194	CcSEcCtD
Rosuvastatin—Arthralgia—Mycophenolic acid—systemic scleroderma	0.000364	0.00194	CcSEcCtD
Rosuvastatin—Infection—Leflunomide—systemic scleroderma	0.000364	0.00194	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Captopril—systemic scleroderma	0.000363	0.00193	CcSEcCtD
Rosuvastatin—Asthenia—Mometasone—systemic scleroderma	0.000363	0.00193	CcSEcCtD
Rosuvastatin—Nervous system disorder—Leflunomide—systemic scleroderma	0.000359	0.00191	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Leflunomide—systemic scleroderma	0.000358	0.00191	CcSEcCtD
Rosuvastatin—Pruritus—Mometasone—systemic scleroderma	0.000358	0.00191	CcSEcCtD
Rosuvastatin—Hepatic failure—Methotrexate—systemic scleroderma	0.000353	0.00188	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Azathioprine—systemic scleroderma	0.000353	0.00188	CcSEcCtD
Rosuvastatin—Angioedema—Lisinopril—systemic scleroderma	0.000352	0.00188	CcSEcCtD
Rosuvastatin—Confusional state—Mycophenolic acid—systemic scleroderma	0.000352	0.00188	CcSEcCtD
Rosuvastatin—Abdominal pain—Captopril—systemic scleroderma	0.000351	0.00187	CcSEcCtD
Rosuvastatin—Nausea—Pentoxifylline—systemic scleroderma	0.000348	0.00185	CcSEcCtD
Rosuvastatin—Infection—Mycophenolic acid—systemic scleroderma	0.000347	0.00185	CcSEcCtD
Rosuvastatin—Arrhythmia—Mycophenolate mofetil—systemic scleroderma	0.000346	0.00185	CcSEcCtD
Rosuvastatin—Diarrhoea—Mometasone—systemic scleroderma	0.000346	0.00184	CcSEcCtD
Rosuvastatin—Renal failure acute—Methotrexate—systemic scleroderma	0.000344	0.00183	CcSEcCtD
Rosuvastatin—Nervous system disorder—Mycophenolic acid—systemic scleroderma	0.000342	0.00182	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Mycophenolic acid—systemic scleroderma	0.000342	0.00182	CcSEcCtD
Rosuvastatin—Mental disorder—Mycophenolate mofetil—systemic scleroderma	0.00034	0.00181	CcSEcCtD
Rosuvastatin—Cough—Lisinopril—systemic scleroderma	0.000336	0.00179	CcSEcCtD
Rosuvastatin—Muscular weakness—Prednisone—systemic scleroderma	0.000335	0.00179	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Leflunomide—systemic scleroderma	0.000333	0.00178	CcSEcCtD
Rosuvastatin—Flatulence—Mycophenolate mofetil—systemic scleroderma	0.000333	0.00177	CcSEcCtD
Rosuvastatin—Insomnia—Leflunomide—systemic scleroderma	0.000331	0.00176	CcSEcCtD
Rosuvastatin—Paraesthesia—Leflunomide—systemic scleroderma	0.000329	0.00175	CcSEcCtD
Rosuvastatin—Myalgia—Lisinopril—systemic scleroderma	0.000328	0.00175	CcSEcCtD
Rosuvastatin—Arthralgia—Lisinopril—systemic scleroderma	0.000328	0.00175	CcSEcCtD
Rosuvastatin—Dyspepsia—Leflunomide—systemic scleroderma	0.000322	0.00172	CcSEcCtD
Rosuvastatin—Pancreatitis—Prednisone—systemic scleroderma	0.000322	0.00172	CcSEcCtD
Rosuvastatin—Feeling abnormal—Azathioprine—systemic scleroderma	0.000319	0.0017	CcSEcCtD
Rosuvastatin—Rash—Mometasone—systemic scleroderma	0.000319	0.0017	CcSEcCtD
Rosuvastatin—Asthenia—Captopril—systemic scleroderma	0.000319	0.0017	CcSEcCtD
Rosuvastatin—Dermatitis—Mometasone—systemic scleroderma	0.000318	0.0017	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Mycophenolic acid—systemic scleroderma	0.000318	0.00169	CcSEcCtD
Rosuvastatin—Confusional state—Lisinopril—systemic scleroderma	0.000317	0.00169	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Azathioprine—systemic scleroderma	0.000317	0.00169	CcSEcCtD
Rosuvastatin—Headache—Mometasone—systemic scleroderma	0.000317	0.00169	CcSEcCtD
Rosuvastatin—Insomnia—Mycophenolic acid—systemic scleroderma	0.000316	0.00168	CcSEcCtD
Rosuvastatin—Pruritus—Captopril—systemic scleroderma	0.000314	0.00167	CcSEcCtD
Rosuvastatin—Paraesthesia—Mycophenolic acid—systemic scleroderma	0.000313	0.00167	CcSEcCtD
Rosuvastatin—Constipation—Leflunomide—systemic scleroderma	0.000313	0.00167	CcSEcCtD
Rosuvastatin—Pain—Leflunomide—systemic scleroderma	0.000313	0.00167	CcSEcCtD
Rosuvastatin—Infection—Lisinopril—systemic scleroderma	0.000312	0.00166	CcSEcCtD
Rosuvastatin—Angioedema—Mycophenolate mofetil—systemic scleroderma	0.000308	0.00164	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Lisinopril—systemic scleroderma	0.000308	0.00164	CcSEcCtD
Rosuvastatin—Dyspepsia—Mycophenolic acid—systemic scleroderma	0.000307	0.00164	CcSEcCtD
Rosuvastatin—Abdominal pain—Azathioprine—systemic scleroderma	0.000306	0.00163	CcSEcCtD
Rosuvastatin—Diarrhoea—Captopril—systemic scleroderma	0.000304	0.00162	CcSEcCtD
Rosuvastatin—Feeling abnormal—Leflunomide—systemic scleroderma	0.000302	0.00161	CcSEcCtD
Rosuvastatin—Nausea—Mometasone—systemic scleroderma	0.0003	0.0016	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Leflunomide—systemic scleroderma	0.000299	0.00159	CcSEcCtD
Rosuvastatin—Pain—Mycophenolic acid—systemic scleroderma	0.000299	0.00159	CcSEcCtD
Rosuvastatin—Constipation—Mycophenolic acid—systemic scleroderma	0.000299	0.00159	CcSEcCtD
Rosuvastatin—Cough—Mycophenolate mofetil—systemic scleroderma	0.000295	0.00157	CcSEcCtD
Rosuvastatin—Dizziness—Captopril—systemic scleroderma	0.000294	0.00156	CcSEcCtD
Rosuvastatin—Depression—Prednisone—systemic scleroderma	0.000292	0.00156	CcSEcCtD
Rosuvastatin—Urticaria—Leflunomide—systemic scleroderma	0.000291	0.00155	CcSEcCtD
Rosuvastatin—Abdominal pain—Leflunomide—systemic scleroderma	0.000289	0.00154	CcSEcCtD
Rosuvastatin—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000288	0.00153	CcSEcCtD
Rosuvastatin—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00153	CcSEcCtD
Rosuvastatin—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000287	0.00153	CcSEcCtD
Rosuvastatin—Neuropathy peripheral—Prednisone—systemic scleroderma	0.000287	0.00153	CcSEcCtD
Rosuvastatin—Breast disorder—Methotrexate—systemic scleroderma	0.000287	0.00153	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.000286	0.00153	CcSEcCtD
Rosuvastatin—Hypersensitivity—Azathioprine—systemic scleroderma	0.000286	0.00152	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.000285	0.00152	CcSEcCtD
Rosuvastatin—Insomnia—Lisinopril—systemic scleroderma	0.000284	0.00152	CcSEcCtD
Rosuvastatin—Paraesthesia—Lisinopril—systemic scleroderma	0.000282	0.0015	CcSEcCtD
Rosuvastatin—Rash—Captopril—systemic scleroderma	0.00028	0.00149	CcSEcCtD
Rosuvastatin—Dermatitis—Captopril—systemic scleroderma	0.00028	0.00149	CcSEcCtD
Rosuvastatin—Headache—Captopril—systemic scleroderma	0.000278	0.00148	CcSEcCtD
Rosuvastatin—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000278	0.00148	CcSEcCtD
Rosuvastatin—Dyspepsia—Lisinopril—systemic scleroderma	0.000277	0.00147	CcSEcCtD
Rosuvastatin—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000276	0.00147	CcSEcCtD
Rosuvastatin—Infection—Mycophenolate mofetil—systemic scleroderma	0.000274	0.00146	CcSEcCtD
Rosuvastatin—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00144	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00027	0.00144	CcSEcCtD
Rosuvastatin—Hypersensitivity—Leflunomide—systemic scleroderma	0.00027	0.00144	CcSEcCtD
Rosuvastatin—Pancreatitis—Methotrexate—systemic scleroderma	0.000269	0.00143	CcSEcCtD
Rosuvastatin—Constipation—Lisinopril—systemic scleroderma	0.000269	0.00143	CcSEcCtD
Rosuvastatin—Pain—Lisinopril—systemic scleroderma	0.000269	0.00143	CcSEcCtD
Rosuvastatin—Diarrhoea—Azathioprine—systemic scleroderma	0.000265	0.00141	CcSEcCtD
Rosuvastatin—Nausea—Captopril—systemic scleroderma	0.000264	0.00141	CcSEcCtD
Rosuvastatin—Asthenia—Leflunomide—systemic scleroderma	0.000263	0.0014	CcSEcCtD
Rosuvastatin—Feeling abnormal—Lisinopril—systemic scleroderma	0.000259	0.00138	CcSEcCtD
Rosuvastatin—Pruritus—Leflunomide—systemic scleroderma	0.000259	0.00138	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000257	0.00137	CcSEcCtD
Rosuvastatin—Dizziness—Azathioprine—systemic scleroderma	0.000256	0.00137	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000251	0.00134	CcSEcCtD
Rosuvastatin—Asthenia—Mycophenolic acid—systemic scleroderma	0.00025	0.00133	CcSEcCtD
Rosuvastatin—Diarrhoea—Leflunomide—systemic scleroderma	0.00025	0.00133	CcSEcCtD
Rosuvastatin—Urticaria—Lisinopril—systemic scleroderma	0.00025	0.00133	CcSEcCtD
Rosuvastatin—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000249	0.00133	CcSEcCtD
Rosuvastatin—Abdominal pain—Lisinopril—systemic scleroderma	0.000249	0.00132	CcSEcCtD
Rosuvastatin—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000247	0.00132	CcSEcCtD
Rosuvastatin—Pruritus—Mycophenolic acid—systemic scleroderma	0.000247	0.00132	CcSEcCtD
Rosuvastatin—Rash—Azathioprine—systemic scleroderma	0.000244	0.0013	CcSEcCtD
Rosuvastatin—Dermatitis—Azathioprine—systemic scleroderma	0.000244	0.0013	CcSEcCtD
Rosuvastatin—Depression—Methotrexate—systemic scleroderma	0.000244	0.0013	CcSEcCtD
Rosuvastatin—Headache—Azathioprine—systemic scleroderma	0.000243	0.00129	CcSEcCtD
Rosuvastatin—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000243	0.00129	CcSEcCtD
Rosuvastatin—Dizziness—Leflunomide—systemic scleroderma	0.000242	0.00129	CcSEcCtD
Rosuvastatin—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000239	0.00127	CcSEcCtD
Rosuvastatin—Pain—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00126	CcSEcCtD
Rosuvastatin—Constipation—Mycophenolate mofetil—systemic scleroderma	0.000236	0.00126	CcSEcCtD
Rosuvastatin—Arrhythmia—Prednisone—systemic scleroderma	0.000235	0.00125	CcSEcCtD
Rosuvastatin—Haematuria—Methotrexate—systemic scleroderma	0.000233	0.00124	CcSEcCtD
Rosuvastatin—Hypersensitivity—Lisinopril—systemic scleroderma	0.000232	0.00123	CcSEcCtD
Rosuvastatin—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000231	0.00123	CcSEcCtD
Rosuvastatin—Dizziness—Mycophenolic acid—systemic scleroderma	0.000231	0.00123	CcSEcCtD
Rosuvastatin—Rash—Leflunomide—systemic scleroderma	0.000231	0.00123	CcSEcCtD
Rosuvastatin—Dermatitis—Leflunomide—systemic scleroderma	0.000231	0.00123	CcSEcCtD
Rosuvastatin—Mental disorder—Prednisone—systemic scleroderma	0.00023	0.00123	CcSEcCtD
Rosuvastatin—Nausea—Azathioprine—systemic scleroderma	0.00023	0.00123	CcSEcCtD
Rosuvastatin—Headache—Leflunomide—systemic scleroderma	0.000229	0.00122	CcSEcCtD
Rosuvastatin—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000227	0.00121	CcSEcCtD
Rosuvastatin—Asthenia—Lisinopril—systemic scleroderma	0.000226	0.0012	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000225	0.0012	CcSEcCtD
Rosuvastatin—Pruritus—Lisinopril—systemic scleroderma	0.000222	0.00119	CcSEcCtD
Rosuvastatin—Rash—Mycophenolic acid—systemic scleroderma	0.00022	0.00117	CcSEcCtD
Rosuvastatin—Dermatitis—Mycophenolic acid—systemic scleroderma	0.00022	0.00117	CcSEcCtD
Rosuvastatin—Hepatitis—Methotrexate—systemic scleroderma	0.00022	0.00117	CcSEcCtD
Rosuvastatin—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.000219	0.00117	CcSEcCtD
Rosuvastatin—Headache—Mycophenolic acid—systemic scleroderma	0.000219	0.00117	CcSEcCtD
Rosuvastatin—Pharyngitis—Methotrexate—systemic scleroderma	0.000218	0.00116	CcSEcCtD
Rosuvastatin—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000218	0.00116	CcSEcCtD
Rosuvastatin—Nausea—Leflunomide—systemic scleroderma	0.000217	0.00116	CcSEcCtD
Rosuvastatin—Diarrhoea—Lisinopril—systemic scleroderma	0.000215	0.00115	CcSEcCtD
Rosuvastatin—Angioedema—Prednisone—systemic scleroderma	0.000209	0.00111	CcSEcCtD
Rosuvastatin—Dizziness—Lisinopril—systemic scleroderma	0.000208	0.00111	CcSEcCtD
Rosuvastatin—Nausea—Mycophenolic acid—systemic scleroderma	0.000207	0.0011	CcSEcCtD
Rosuvastatin—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000203	0.00108	CcSEcCtD
Rosuvastatin—Rash—Lisinopril—systemic scleroderma	0.000198	0.00106	CcSEcCtD
Rosuvastatin—Dermatitis—Lisinopril—systemic scleroderma	0.000198	0.00106	CcSEcCtD
Rosuvastatin—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000198	0.00105	CcSEcCtD
Rosuvastatin—Headache—Lisinopril—systemic scleroderma	0.000197	0.00105	CcSEcCtD
Rosuvastatin—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000195	0.00104	CcSEcCtD
Rosuvastatin—Myalgia—Prednisone—systemic scleroderma	0.000195	0.00104	CcSEcCtD
Rosuvastatin—Arthralgia—Prednisone—systemic scleroderma	0.000195	0.00104	CcSEcCtD
Rosuvastatin—Mental disorder—Methotrexate—systemic scleroderma	0.000192	0.00103	CcSEcCtD
Rosuvastatin—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000189	0.001	CcSEcCtD
Rosuvastatin—Nausea—Lisinopril—systemic scleroderma	0.000187	0.000995	CcSEcCtD
Rosuvastatin—Infection—Prednisone—systemic scleroderma	0.000186	0.000989	CcSEcCtD
Rosuvastatin—Nervous system disorder—Prednisone—systemic scleroderma	0.000183	0.000976	CcSEcCtD
Rosuvastatin—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000182	0.000971	CcSEcCtD
Rosuvastatin—Rash—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000926	CcSEcCtD
Rosuvastatin—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000174	0.000925	CcSEcCtD
Rosuvastatin—Headache—Mycophenolate mofetil—systemic scleroderma	0.000173	0.00092	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.00017	0.000907	CcSEcCtD
Rosuvastatin—Insomnia—Prednisone—systemic scleroderma	0.000169	0.0009	CcSEcCtD
Rosuvastatin—Paraesthesia—Prednisone—systemic scleroderma	0.000168	0.000894	CcSEcCtD
Rosuvastatin—Cough—Methotrexate—systemic scleroderma	0.000167	0.000889	CcSEcCtD
Rosuvastatin—Dyspepsia—Prednisone—systemic scleroderma	0.000164	0.000876	CcSEcCtD
Rosuvastatin—Nausea—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000872	CcSEcCtD
Rosuvastatin—Arthralgia—Methotrexate—systemic scleroderma	0.000163	0.000868	CcSEcCtD
Rosuvastatin—Myalgia—Methotrexate—systemic scleroderma	0.000163	0.000868	CcSEcCtD
Rosuvastatin—Constipation—Prednisone—systemic scleroderma	0.00016	0.000851	CcSEcCtD
Rosuvastatin—Confusional state—Methotrexate—systemic scleroderma	0.000157	0.000839	CcSEcCtD
Rosuvastatin—Infection—Methotrexate—systemic scleroderma	0.000155	0.000826	CcSEcCtD
Rosuvastatin—Feeling abnormal—Prednisone—systemic scleroderma	0.000154	0.00082	CcSEcCtD
Rosuvastatin—Nervous system disorder—Methotrexate—systemic scleroderma	0.000153	0.000816	CcSEcCtD
Rosuvastatin—Thrombocytopenia—Methotrexate—systemic scleroderma	0.000153	0.000814	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Prednisone—systemic scleroderma	0.000153	0.000814	CcSEcCtD
Rosuvastatin—Urticaria—Prednisone—systemic scleroderma	0.000148	0.000791	CcSEcCtD
Rosuvastatin—Abdominal pain—Prednisone—systemic scleroderma	0.000148	0.000787	CcSEcCtD
Rosuvastatin—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	0.000142	0.000758	CcSEcCtD
Rosuvastatin—Insomnia—Methotrexate—systemic scleroderma	0.000141	0.000752	CcSEcCtD
Rosuvastatin—Paraesthesia—Methotrexate—systemic scleroderma	0.00014	0.000747	CcSEcCtD
Rosuvastatin—Hypersensitivity—Prednisone—systemic scleroderma	0.000138	0.000733	CcSEcCtD
Rosuvastatin—Dyspepsia—Methotrexate—systemic scleroderma	0.000137	0.000732	CcSEcCtD
Rosuvastatin—Asthenia—Prednisone—systemic scleroderma	0.000134	0.000714	CcSEcCtD
Rosuvastatin—Pain—Methotrexate—systemic scleroderma	0.000133	0.000711	CcSEcCtD
Rosuvastatin—Pruritus—Prednisone—systemic scleroderma	0.000132	0.000704	CcSEcCtD
Rosuvastatin—Feeling abnormal—Methotrexate—systemic scleroderma	0.000129	0.000685	CcSEcCtD
Rosuvastatin—Diarrhoea—Prednisone—systemic scleroderma	0.000128	0.000681	CcSEcCtD
Rosuvastatin—Gastrointestinal pain—Methotrexate—systemic scleroderma	0.000128	0.00068	CcSEcCtD
Rosuvastatin—Urticaria—Methotrexate—systemic scleroderma	0.000124	0.000661	CcSEcCtD
Rosuvastatin—Dizziness—Prednisone—systemic scleroderma	0.000123	0.000658	CcSEcCtD
Rosuvastatin—Abdominal pain—Methotrexate—systemic scleroderma	0.000123	0.000657	CcSEcCtD
Rosuvastatin—Rash—Prednisone—systemic scleroderma	0.000118	0.000627	CcSEcCtD
Rosuvastatin—Dermatitis—Prednisone—systemic scleroderma	0.000118	0.000627	CcSEcCtD
Rosuvastatin—Headache—Prednisone—systemic scleroderma	0.000117	0.000623	CcSEcCtD
Rosuvastatin—Hypersensitivity—Methotrexate—systemic scleroderma	0.000115	0.000613	CcSEcCtD
Rosuvastatin—Asthenia—Methotrexate—systemic scleroderma	0.000112	0.000597	CcSEcCtD
Rosuvastatin—Nausea—Prednisone—systemic scleroderma	0.000111	0.000591	CcSEcCtD
Rosuvastatin—Pruritus—Methotrexate—systemic scleroderma	0.00011	0.000588	CcSEcCtD
Rosuvastatin—Diarrhoea—Methotrexate—systemic scleroderma	0.000107	0.000569	CcSEcCtD
Rosuvastatin—Dizziness—Methotrexate—systemic scleroderma	0.000103	0.00055	CcSEcCtD
Rosuvastatin—Rash—Methotrexate—systemic scleroderma	9.84e-05	0.000524	CcSEcCtD
Rosuvastatin—Dermatitis—Methotrexate—systemic scleroderma	9.83e-05	0.000524	CcSEcCtD
Rosuvastatin—Headache—Methotrexate—systemic scleroderma	9.78e-05	0.000521	CcSEcCtD
Rosuvastatin—Nausea—Methotrexate—systemic scleroderma	9.27e-05	0.000494	CcSEcCtD
